Upregulation of NLRP3 inflammasome in the tears and ocular surface of dry eye patients

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Niu, Liangliang ^a   Zhang, Shujie ^a   Wu, Jihong ^a   Chen, Ling ^a,b   Wang, Yan ^a  

^a EYE AND ENT HOSPITAL OF FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; FLUORESCEIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; CARRIER PROTEIN; MESSENGER RNA; NLRP3 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; DRY EYE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; IMPRESSION CYTOLOGY; INFLAMMATION; LACRIMAL FLUID; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIRMER TEST; SJOEGREN SYNDROME; STAINING; TEAR FILM; UPREGULATION; WESTERN BLOTTING; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADULT; CARRIER PROTEINS; CASPASE 1; DRY EYE SYNDROMES; FEMALE; HUMANS; INFLAMMASOMES; INTERLEUKIN-18; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; PROSPECTIVE STUDIES; RNA, MESSENGER; TEARS;

EID: 84930663126     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126277     Document Type: Article

References (38)

1. Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 2012; 130(1):90-100. doi: 10.1001/archophthalmol.2011.364 PMID: 22232476
2. Stern ME, Schaumburg CS, Pflugfelder SC. Dry eye as a mucosal autoimmune disease. Int Rev Immunol. 2013; 32(1):19-41. doi: 10.3109/08830185.2012.748052 PMID: 23360156
3. Yoon KC, Park CS, You IC, Choi HJ, Lee KH, Im SK, et al. Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome. IOVS. 2010; 51(2):643-650. doi: 10.1167/iovs.09-3425 PMID: 19850844
4. Epstein SP, Gadaria-Rathod N, Wei Y, Maguire MG, Asbell PA. HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease. Exp Eye Res. 2013; 6(111C):95-104.
5. Choi W, Li Z, Oh HJ, Im SK, Lee SH, Park SH, et al. Expression of CCR5 and its ligands CCL3, -4, and -5 in the tear film and ocular surface of patients with dry eye disease. Curr Eye Res. 2012; 37(1):12-17. doi: 10.3109/02713683.2011.622852 PMID: 22029739
6. Barabino S, Chen Y, Chauhan S, Dana R. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res. 2012; 31(3):271-285. doi: 10.1016/j.preteyeres.2012.02.003 PMID: 22426080
7. Massingale ML, Li X, Vallabhajosyula M, Chen D, Wei Y, Asbell PA. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea. 2009; 28(9):1023-1027. doi: 10.1097/ICO.0b013e3181a16578 PMID: 19724208
8. Brignole F, Pisella P-J, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. IOVS. 2000; 41 (6):1356-1363.
9. Lam H, Bleiden L, de Paiva CS, Farley W, Stern ME, Pflugfelder SC. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009; 147(2):198-205. doi: 10.1016/j.ajo.2008.08.032 PMID: 18992869
10. Roescher N, Tak PP, Illei GG. Cytokines in Sjögren's syndrome: potential therapeutic targets. Ann Rheum Dis. 2010; 69(6):945-948. doi: 10.1136/ard.2009.115378 PMID: 20410069
11. Hoffman HM, Wanderer AA. Inflammasome and IL-1beta-mediated disorders. Curr Allergy Asthma Rep. 2010; 10(4):229-235. doi: 10.1007/s11882-010-0109-z PMID: 20425006
12. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol Cell. 2002; 10(2):417-426. PMID: 12191486
13. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1βprocessing inflammasome with increased activity in Muckle - Wells autoinflammatory disorder. Immunity. 2004; 20(3):319-325. PMID: 15030775
14. Im H, Ammit AJ. The NLRP3 inflammasome: role in airway inflammation. Clin Exp Allergy. 2014; 44 (2):160-172. doi: 10.1111/cea.12206 PMID: 24118105
15. Andersen K, Eltrich N, Lichtnekert J, Anders HJ, Vielhauer V. The NLRP3/ASC inflammasome promotes T-cell-dependent immune complex glomerulonephritis by canonical and noncanonical mechanisms. Kidney Int. 2014; 86(5):965-78. doi: 10.1038/ki.2014.161 PMID: 24805106
16. Jankovic D, Ganesan J, Bscheider M, Stickel N, Weber FC, Guarda G, et al. The Nlrp3 inflammasome regulates acute graft-versus-host disease. J Exp Med. 2013; 210(10):1899-1910. doi: 10.1084/jem.20130084 PMID: 23980097
17. Kahlenberg JM, Kaplan MJ. The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis? Curr Opin Rheumatol. 2014; 26(5):475-481. doi: 10.1097/BOR.0000000000000088 PMID: 24992143
18. Benetti E, Chiazza F, Patel NS, Collino M. The NLRP3 Inflammasome as a novel player of the intercellular crosstalk in metabolic disorders. Mediators Inflamm. 2013; 678627. doi: 10.1155/2013/678627 PMID: 23843683
19. Rock KL, Kataoka H, Lai J-J. Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol. 2013; 9(1):13-23. doi: 10.1038/nrrheum.2012.143 PMID: 22945591
20. Campbell M, Doyle SL. An eye on the future of inflammasomes and drug development in AMD. J Mol Med (Berl). 2013; 91(9):1059-70. doi: 10.1007/s00109-013-1050-0 PMID: 23661041
21. Marneros AG. NLRP3 inflammasome blockade inhibits VEGF-A-induced age-related macular degeneration. Cell Rep. 2013; 4(5):945-958. doi: 10.1016/j.celrep.2013.08.002 PMID: 24012762
22. Doyle SL, Campbell M, Ozaki E, Salomon RG, Mori A, Kenna PF, et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat Med. 2012; 18(5):791-798. doi: 10.1038/nm.2717 PMID: 22484808
23. Zheng Q, Ren Y, Reinach PS. Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye. Exp Eye Res. 2014; 125C:1-8.
24. Wang Y, Dogru M, Matsumoto Y, Ward SK, Ayako I, Hu Y, et al. The impact of nasal conjunctivochalasis on tear functions and ocular surface findings. Am J Ophthalmol. 2007; 144(6):930-937. PMID: 17916317
25. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American - European Consensus Group. Ann Rheum Dis. 2002; 61(6):554-558. PMID: 12006334
26. Toda I, Tsubota K. Practical double vital staining for ocular surface evaluation. Cornea. 1993; 12 (4):366-367. PMID: 7687944
27. Lee SY, Han SJ, Nam SM, Yoon SC, Ahn JM, Kim TI, et al. Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients. Am J Ophthalmol. 2013; 156(2):247-253. doi: 10.1016/j.ajo.2013.04.003 PMID: 23752063
28. Caffery B, Joyce E, Heynen ML, Jones L, Ritter R 3rd, Gamache DA, et al. MUC16 expression in Sjögren's syndrome, KCS, and control subjects. Mol Vis. 2008; 14:2547-2555. PMID: 19122828
29. Caffery B, Heynen ML, Joyce E, Jones L, Ritter R 3rd, Senchyna M. MUC1 expression in Sjögren's syndrome, KCS, and control subjects. Mol Vis. 2010; 16:1720-1727. PMID: 20806091
30. Lamkanfi M, Dixit VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol. 2012; 28:137-161. doi: 10.1146/annurev-cellbio-101011-155745 PMID: 22974247
31. Baldini C, Rossi C, Ferro F, Santini E, Seccia V, Donati V, et al. The P2X7 receptor-inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome. J Intern Med. 2013; 274(5):480-9. doi: 10.1111/joim.12115 PMID: 23906036
32. Lamkanfi M. Emerging inflammasome effector mechanisms. Nat Rev Immunol. 2011; 11(3):213-220. doi: 10.1038/nri2936 PMID: 21350580
33. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009; 27:519-550. doi: 10.1146/annurev.immunol.021908.132612 PMID: 19302047
34. Zoukhri D, Hodges RR, Byon D, Kublin CL. Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia. Invest Ophthalmol Vis Sci. 2002; 43(5):1429-1436. PMID: 11980857
35. Kimura-Shimmyo A, Kashiwamura S, Ueda H, Ikeda T, Kanno S, Akira S, et al. Cytokine-induced injury of the lacrimal and salivary glands. J Immunother. 2002; 25 Suppl 1:S42-S51. PMID: 12048350
36. Boyden ED, Dietrich WF. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet. 2006; 38(2):240-4. PMID: 16429160
37. Cassel SL, Sutterwala FS. Sterile inflammatory responses mediated by the NLRP3 inflammasome. Eur J Immunol. 2010; 40(3):607-11. doi: 10.1002/eji.200940207 PMID: 20201012
38. Lemp M, Baudouin C, Baum J, Dogru M, Foulks GN, Kinoshita S, et al. The definition and classification of dry eye: report of the definition and classification subcommittee of the international dry eye workshop. 0cul Surf. 2007; 5:75-92.